The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia

Theodore E. Warkentin; Jane C. Moore; Susan Vogel; Jo-Ann I. Sheppard; Nathan I. Warkentin; John W. Eikelboom

doi:10.1160/TH11-12-0839

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2012; 107(05): 998-1000
DOI: 10.1160/TH11-12-0839

Letters to the Editor

Schattauer GmbH

The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia

Authors

Theodore E. Warkentin

¹Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

²Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Jane C. Moore

¹Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

²Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Susan Vogel

³Intensive Care Unit, Hamilton Health Sciences, Hamilton, Ontario, Canada
Jo-Ann I. Sheppard

¹Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Nathan I. Warkentin

¹Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
John W. Eikelboom

²Department of Medicine, McMaster University, Hamilton, Ontario, Canada

Abstract

Full Text

References

References
1 Selleng S, Malowsky B, Strobel U. et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost 2010; 08: 30-36.
2 Pouplard C, May MA, Regina S. et al. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 2005; 128: 837-841.
3 Selleng S, Selleng K, Wollert HG. et al. Heparin-in-duced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopul-monary bypass. J Thromb Haemost 2008; 06: 428-435.
4 Pouplard C, Leroux D, Regina S. et al. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies. Thromb Haemost 2010; 103: 145-150.
5 Horsewood P, Warkentin TE, Hayward CPM. et al. The epitope specificity of heparin-induced throm-bocytopenia. Br J Haematol 1996; 95: 161-167.
6 Warkentin TE, Sheppard JI, Moore JC. et al. Studies of the immune response in heparin-induced thrombocytopenia. Blood 2009; 113: 4963-4969.
7 Socher I, Kroll H, Jorks S. et al. Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies: a common occurrence. J Thromb Haemost 2008; 06: 197-200.
8 Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135: 502-506.
9 Linkins LA, Warkentin TE. Heparin-induced thrombocytopenia: real-world issues. Semin Thromb Hemost 2011; 37: 653-663.
10 Taaning E, Tonnesen F. Pan-reactive platelet antibodies in post-transfusion purpura. Vox Sang 1999; 76: 120-123.